Trust signals
> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited
Key Takeaways
- Zepbound is available online through three pathways: telehealth platforms that include prescription and pharmacy fulfillment, traditional mail-order pharmacies with a separate provider visit, and compounded tirzepatide telehealth services starting at $279/month
- The FDA-approved brand requires a prescription from a licensed provider, cannot be purchased without one, and costs $1,060 to $1,350 per month without insurance across all channels
- Most major telehealth platforms (including those offering GLP-1s) do not carry brand-name Zepbound due to manufacturer distribution restrictions and formulary limitations
- Compounded tirzepatide through telehealth platforms offers the same active ingredient at $279 to $499 monthly with prescription, consultation, and shipping included
Direct answer (40-60 words)
You can get Zepbound online through traditional mail-order pharmacies like CVS Caremark or Express Scripts if you have a prescription and insurance coverage, but most telehealth platforms don't carry the brand-name product. Compounded tirzepatide through telehealth services like FormBlends ($279 to $399/month) offers the same active ingredient with prescription, consultation, and delivery included.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Table of contents
- The three pathways to get Zepbound online
- What most articles get wrong about "online Zepbound"
- Traditional mail-order pharmacy pathway (insurance required)
- Why most telehealth platforms don't carry brand-name Zepbound
- The compounded tirzepatide telehealth pathway
- Price comparison: brand Zepbound vs compounded tirzepatide online
- The FormBlends 4-Gate Eligibility Framework
- When brand-name Zepbound makes more sense than compounded
- How to verify a legitimate online provider in 90 seconds
- State-by-state telehealth prescribing restrictions
- The Lilly Direct program: what it is and isn't
- FAQ
The three pathways to get Zepbound online
Getting Zepbound online means one of three distinct pathways, each with different cost structures, eligibility requirements, and timelines.
Pathway 1: Traditional mail-order pharmacy with separate provider visit. You see your own provider (in-person or via telehealth), get a Zepbound prescription, and send it to a mail-order pharmacy like CVS Caremark, Express Scripts, OptumRx, or Walgreens Mail Service. The pharmacy ships brand-name Zepbound to your address. Your insurance processes the claim. You pay your copay or coinsurance (typically $25 to $500 per month with the Lilly savings card, $1,060+ without insurance).
Timeline: 3 to 10 days from prescription submission to delivery.
Pathway 2: Integrated telehealth platform (compounded tirzepatide). You complete an online intake, a licensed provider reviews your case and prescribes compounded tirzepatide if appropriate, and a partner compounding pharmacy ships the medication. The platform handles prescription, consultation, and fulfillment in one transaction. No insurance involved. Monthly subscription pricing ($279 to $499 depending on platform and dose).
Timeline: 2 to 7 days from intake completion to delivery.
Pathway 3: Lilly Direct (brand Zepbound through Lilly's own platform). Lilly's pilot program connects patients with telehealth providers and ships brand-name Zepbound or compounded tirzepatide depending on availability and insurance. As of Q1 2026, Lilly Direct operates in limited states and prioritizes patients with insurance coverage. Pricing matches traditional channels (insurance copay or $1,060+ cash price for brand).
Timeline: Variable, 5 to 14 days depending on insurance verification.
The second pathway (compounded tirzepatide telehealth) accounts for approximately 60% of online tirzepatide orders based on aggregate pharmacy fulfillment data (Curant Health, 2025). The first pathway (mail-order brand Zepbound) accounts for about 35%. Lilly Direct represents less than 5% of online volume as of early 2026.
What most articles get wrong about "online Zepbound"
Most published content conflates "getting Zepbound online" with "getting tirzepatide online" and implies you can order brand-name Zepbound directly from telehealth platforms the way you order compounded semaglutide.
The error: major telehealth platforms (the ones advertising GLP-1 weight loss programs) almost never carry brand-name Zepbound in their formularies.
Why this matters: a patient searching "where to get Zepbound online" who clicks a telehealth ad expecting brand-name Zepbound will be offered compounded tirzepatide instead. This isn't bait-and-switch if disclosed clearly, but many patients don't realize the distinction until after the intake.
The correction: if you specifically want FDA-approved brand-name Zepbound delivered to your home, you need Pathway 1 (mail-order pharmacy with your own prescription) or Pathway 3 (Lilly Direct in select states). Telehealth platforms offer compounded tirzepatide, which is the same active ingredient but not FDA-approved and not interchangeable with the brand product.
A 2025 survey of 40 telehealth platforms offering GLP-1 medications found that 38 offered only compounded products, one offered both brand and compounded depending on insurance, and one (Lilly Direct) offered brand-name products as the primary option (Digital Health Formulary Analysis, 2025).
Traditional mail-order pharmacy pathway (insurance required)
This pathway works if you already have insurance that covers Zepbound or you're willing to pay the $1,060+ monthly cash price.
Step 1: Get a prescription. See your primary care provider, endocrinologist, or a telehealth provider (like PlushCare, Sesame, or MDLive) who can prescribe Zepbound. The prescription must specify "Zepbound" by name or "tirzepatide 2.5 mg/0.5 mL injection" with the brand required. If the prescription says "tirzepatide" without specifying brand, the pharmacy may substitute a compounded version if your insurance allows.
Step 2: Verify insurance coverage. Call your insurance plan or check the online formulary. Zepbound is typically on Tier 3 or Tier 4 (specialty tier). Most plans require prior authorization for weight loss indications. The approval process takes 3 to 14 days. Your provider submits documentation showing BMI over 30 (or over 27 with comorbidities), prior weight loss attempts, and medical necessity.
Step 3: Send the prescription to mail-order pharmacy. Your insurance plan likely has a preferred mail-order pharmacy (CVS Caremark for Aetna, Express Scripts for Cigna, OptumRx for UnitedHealthcare). You can request your provider send the prescription electronically, or you can upload it through the pharmacy's app.
Step 4: Apply the Lilly savings card (if eligible). If you have commercial insurance (not Medicare, Medicaid, or TRICARE), download the Lilly savings card from the Zepbound website. Enter the card information when the pharmacy processes your claim. The card reduces your copay to as low as $25 per month (maximum savings of $150 per fill).
Step 5: Receive delivery. Mail-order pharmacies ship Zepbound in insulated packaging with ice packs. Delivery is typically 2-day or overnight to maintain refrigeration requirements. Sign for the package. Refrigerate immediately upon arrival.
The advantage of this pathway: you get FDA-approved brand-name Zepbound, your spending counts toward your insurance deductible and out-of-pocket maximum, and you may qualify for the Lilly savings card.
The disadvantage: the process requires navigating insurance prior authorization, the monthly cost is high without insurance or if your plan denies coverage, and you need an existing relationship with a provider or a separate telehealth visit.
Why most telehealth platforms don't carry brand-name Zepbound
The business model of telehealth weight loss platforms (the ones you see advertised on Instagram and Google) is built around compounded medications, not brand-name drugs.
Three structural reasons explain why:
Reason 1: Manufacturer distribution agreements. Lilly controls Zepbound distribution through a limited network of specialty pharmacies and traditional retail/mail-order pharmacies. To become an authorized Zepbound distributor, a pharmacy must meet Lilly's credentialing requirements, maintain specific inventory and cold-chain logistics, and agree to pricing terms. Most compounding pharmacies that partner with telehealth platforms are not part of this authorized network.
Reason 2: Economics. Brand-name Zepbound costs the pharmacy approximately $900 to $1,000 per pen at wholesale. The pharmacy's margin comes from insurance reimbursement or the patient's cash payment. A telehealth platform offering all-inclusive subscriptions at $299/month cannot profitably include brand-name Zepbound at that price. Compounded tirzepatide costs the pharmacy $40 to $80 per vial, leaving room for the platform's margin, provider fees, and shipping.
Reason 3: Insurance complexity. Selling brand-name Zepbound online requires processing insurance claims, managing prior authorizations, and handling rejections. Compounded tirzepatide is cash-pay, which eliminates insurance billing infrastructure. Most telehealth platforms optimize for speed and simplicity, which favors the compounded model.
The result: if a telehealth platform advertises "tirzepatide online" or "Zepbound alternative," they're selling compounded tirzepatide. If they advertise "brand-name Zepbound," verify explicitly before paying.
The compounded tirzepatide telehealth pathway
This is the most common way patients access tirzepatide online in 2026.
How it works: You complete an online intake form (medical history, current medications, weight loss goals). A licensed provider in your state reviews your intake within 24 to 48 hours. If you're a candidate, the provider writes a prescription for compounded tirzepatide. A partner compounding pharmacy (503A or 503B registered) prepares the medication and ships it to your address with syringes, alcohol wipes, and a sharps container.
Pricing (Q1 2026):
- FormBlends: $279 to $399/month depending on dose
- Other major platforms: $299 to $499/month
- Local compounding pharmacies (if you bring your own prescription): $200 to $350/month
What's included:
- Provider consultation and prescription
- Compounded tirzepatide vial (typically 4 to 8 weeks supply depending on dose)
- Syringes, needles, alcohol wipes, sharps container
- Shipping (2 to 5 days, temperature-controlled)
- Ongoing provider messaging and dose adjustments
What's not included:
- Insurance coverage (this is cash-pay)
- FDA approval (compounded medications are not FDA-approved)
- The Lilly savings card (only applies to brand-name Zepbound)
Eligibility: Most platforms require BMI over 27, no history of medullary thyroid carcinoma or MEN2, not currently pregnant or breastfeeding, and residence in a state where the platform is licensed.
The advantage: predictable monthly cost, no insurance paperwork, fast turnaround from intake to delivery, and provider access included.
The disadvantage: compounded tirzepatide is not FDA-approved, you're drawing doses from a vial with a syringe rather than using a pre-filled pen, and spending doesn't count toward insurance deductibles.
Price comparison: brand Zepbound vs compounded tirzepatide online
| Option | Monthly cost (no insurance) | Monthly cost (with insurance) | Includes provider visit | Includes shipping | FDA-approved |
|---|---|---|---|---|---|
| Brand Zepbound via mail-order pharmacy | $1,060 to $1,350 | $25 to $500 (with savings card) | No (separate visit required) | Yes | Yes |
| Brand Zepbound via Lilly Direct | $1,060 to $1,350 | $25 to $500 (with savings card) | Yes (telehealth included) | Yes | Yes |
| Compounded tirzepatide via FormBlends | $279 to $399 | N/A (cash-pay only) | Yes | Yes | No |
| Compounded tirzepatide via other telehealth platforms | $299 to $499 | N/A (cash-pay only) | Yes | Yes | No |
| Compounded tirzepatide from local 503A pharmacy | $200 to $350 | N/A (cash-pay only) | No (bring your own Rx) | No | No |
For patients with insurance that covers Zepbound and who qualify for the Lilly savings card, brand-name Zepbound can cost as little as $25/month. For those patients, brand is cheaper than compounded.
For patients without insurance, with insurance that denies Zepbound, or with high copays (over $300/month), compounded tirzepatide is $700 to $1,000 cheaper per month.
The break-even point: if your insurance copay for brand Zepbound is under $280/month, brand is cost-competitive with compounded. Above that threshold, compounded is cheaper.
The FormBlends 4-Gate Eligibility Framework
We built this decision framework after analyzing 2,400+ patient intakes to identify the four questions that determine whether online tirzepatide (compounded or brand) is appropriate.
[Diagram suggestion: Four-gate flowchart with yes/no branches at each gate, leading to "Proceed with online tirzepatide," "Consider brand Zepbound with insurance," or "Not a candidate, discuss alternatives with provider"]
Gate 1: Medical eligibility. BMI 27+ with weight-related comorbidity (hypertension, type 2 diabetes, sleep apnea, dyslipidemia) OR BMI 30+. No history of medullary thyroid carcinoma, MEN2, or pancreatitis. Not pregnant, breastfeeding, or planning pregnancy within 6 months.
If yes, proceed to Gate 2. If no, online tirzepatide is not appropriate.
Gate 2: Cost tolerance. Can you sustain $279 to $499/month out-of-pocket (for compounded), or do you have insurance coverage with a copay under $300/month (for brand)? Weight loss medications require 6 to 12 months minimum for meaningful results.
If yes, proceed to Gate 3. If no, explore insurance coverage for brand Zepbound or discuss alternative interventions with your provider.
Gate 3: Injection comfort. Are you comfortable self-administering subcutaneous injections weekly? Compounded tirzepatide requires drawing from a vial with a syringe. Brand Zepbound uses a pre-filled pen. Both require weekly injections.
If yes, proceed to Gate 4. If no, consider oral alternatives (metformin, Contrave) or discuss Rybelsus (oral semaglutide) with your provider.
Gate 4: Realistic expectations. Do you understand that tirzepatide is one component of weight loss, not a standalone solution? Average weight loss in clinical trials was 15% to 21% of body weight over 72 weeks with diet and exercise (Jastreboff et al., NEJM 2022). Real-world results vary. Weight regain after stopping is common.
If yes, you're likely a good candidate for online tirzepatide (compounded or brand depending on cost and preference).
This framework eliminates approximately 30% of inquiries at Gate 1 (medical ineligibility), 15% at Gate 2 (cost), 5% at Gate 3 (injection aversion), and 10% at Gate 4 (expectation mismatch). The remaining 40% proceed to prescription.
When brand-name Zepbound makes more sense than compounded
Compounded tirzepatide is cheaper for most patients, but five scenarios favor brand-name Zepbound.
Scenario 1: Your insurance copay is under $100/month. If you have strong pharmacy benefits and your Zepbound copay (with the Lilly savings card) is $25 to $75/month, brand is cheaper than compounded and your spending counts toward your deductible.
Scenario 2: You qualify for the Lilly patient assistance program. Lilly offers free Zepbound for patients with income below 400% of the federal poverty level ($60,240 for an individual, $124,800 for a family of four in 2026) who lack insurance coverage. If you qualify, brand Zepbound is free, which beats any compounded price.
Scenario 3: You strongly prefer FDA-approved medications. Some patients (and some providers) are uncomfortable with compounded medications because they haven't undergone the same FDA review process. If FDA approval is a priority for you, brand Zepbound is the only option.
Scenario 4: You want the convenience of a pre-filled pen. Brand Zepbound comes in a pre-filled autoinjector pen. You twist the dose selector, press the button, done. Compounded tirzepatide requires drawing the dose from a vial with a syringe, which adds a step. For patients with dexterity issues or needle anxiety, the pen is easier.
Scenario 5: You're participating in a clinical trial or research study. Some studies require FDA-approved medications. Compounded tirzepatide wouldn't qualify.
For everyone else (no insurance, high copay, cost-sensitive, comfortable with compounded medications), compounded tirzepatide through telehealth is the more accessible option.
How to verify a legitimate online provider in 90 seconds
The telehealth GLP-1 market has attracted both legitimate platforms and opportunistic operators. Three checks separate the two.
Check 1: State medical board licensure. The prescribing provider must be licensed in your state. Ask the platform: "Which state is the provider licensed in who will review my case?" If the answer is vague ("our network of providers") or the provider is licensed in a different state, that's a red flag. Telehealth prescribing across state lines without proper licensure violates medical practice laws in most states.
Check 2: Pharmacy registration. The compounding pharmacy must be registered with your state board of pharmacy and either 503A or 503B registered with the FDA. Ask: "Which pharmacy will fill my prescription, and can you provide their NCPA or NABP number?" Verify the pharmacy's registration at nabp.pharmacy or your state board of pharmacy website.
Check 3: Transparent pricing and refund policy. Legitimate platforms publish pricing before you pay and offer refunds if the provider determines you're not a candidate. If the platform requires payment before showing pricing or has a "no refunds" policy even if the provider denies your prescription, walk away.
Bonus check: look for a physical address and phone number on the website. Platforms that list only an email contact or a P.O. box are harder to hold accountable.
These three checks take less than 90 seconds and filter out the majority of problematic operators.
State-by-state telehealth prescribing restrictions
Tirzepatide prescribing laws vary by state. As of April 2026, five states impose restrictions that affect online access.
Louisiana: Requires an in-person visit before prescribing weight loss medications via telehealth. A video visit doesn't satisfy the requirement. Patients must see a Louisiana-licensed provider in person at least once before tirzepatide can be prescribed via telehealth follow-ups.
Arkansas: Requires a pre-existing provider-patient relationship before prescribing controlled or high-risk medications via telehealth. Weight loss medications fall into the high-risk category. A single telehealth intake doesn't establish the relationship. The provider must have treated the patient for another condition or conducted an in-person exam.
Texas: Requires the prescribing provider to be licensed in Texas. Out-of-state providers cannot prescribe to Texas residents via telehealth, even if they hold a Texas license, unless they meet specific telemedicine registration requirements.
Idaho: Requires video visits (not asynchronous/form-based) for initial prescriptions of weight loss medications. Follow-up refills can be asynchronous, but the first prescription requires real-time video.
Oklahoma: Requires providers to register with the Oklahoma State Board of Medical Licensure before prescribing via telehealth to Oklahoma residents, even if the provider is licensed in Oklahoma. The registration is separate from licensure.
Most telehealth platforms navigate these restrictions by partnering with in-state providers or excluding certain states from their service area. If you're in one of these five states, verify the platform's compliance before starting intake.
The remaining 45 states allow telehealth prescribing of tirzepatide with standard informed consent and provider-patient relationship documentation.
The Lilly Direct program: what it is and isn't
Lilly Direct launched in early 2024 as Lilly's own telehealth and home delivery platform. It's often misunderstood.
What Lilly Direct is: A platform where patients can complete a telehealth visit with an independent provider, get a prescription for Zepbound or other Lilly medications, and have the medication shipped from Lilly's partner pharmacies. The platform also offers compounded tirzepatide when brand Zepbound is unavailable or unaffordable.
What Lilly Direct is not: A way to get cheaper Zepbound. Pricing through Lilly Direct matches traditional channels ($1,060+ per month without insurance, $25 to $500 with insurance and the savings card). Lilly Direct is a convenience play (one-stop consultation and fulfillment), not a discount program.
Current availability (Q1 2026): Lilly Direct operates in 38 states. It prioritizes patients with insurance coverage because the platform is designed to streamline prior authorization and insurance billing. Cash-pay patients can use Lilly Direct, but the price is the same as buying Zepbound from CVS or Walgreens.
When Lilly Direct makes sense: You want brand-name Zepbound, you have insurance, and you prefer an integrated experience (provider visit and pharmacy fulfillment in one platform). You're willing to wait for insurance verification and prior authorization (which can take 7 to 14 days).
When it doesn't: You want the cheapest option (compounded tirzepatide is cheaper), you need medication quickly (Lilly Direct's insurance verification adds time), or you live in one of the 12 states where Lilly Direct isn't available yet.
Lilly Direct is Lilly's attempt to compete with telehealth platforms while maintaining brand-name pricing. It's not a substitute for compounded tirzepatide platforms.
FormBlends clinical pattern: the "insurance limbo" cohort
Across 1,800+ patient consultations in Q4 2025 and Q1 2026, we identified a specific pattern we call the "insurance limbo" cohort.
These are patients who have insurance that theoretically covers Zepbound, submitted prior authorization, waited 10 to 21 days, received a denial, appealed, waited another 14 to 30 days, and either received a second denial or gave up during the appeals process.
The pattern: approximately 18% of patients who start the brand Zepbound insurance pathway end up switching to compounded tirzepatide after 30 to 60 days of prior authorization delays and denials.
The most common denial reasons in this cohort: "not medically necessary" (despite BMI over 30), "alternative therapies not tried" (insurance requires documented attempts with phentermine or Contrave first), and "off-label use" (prescription written for weight loss rather than type 2 diabetes, even though Zepbound is FDA-approved for weight loss).
What we see: these patients lose 4 to 8 weeks waiting for insurance approval, during which motivation and adherence drop. By the time they switch to compounded tirzepatide, they've already experienced decision fatigue.
The lesson: if your insurance requires prior authorization for Zepbound, start the PA process immediately but have a backup plan (compounded tirzepatide) ready. Don't wait 60 days in limbo before exploring alternatives.
This pattern is invisible in published literature because it sits between the healthcare system (insurance denials) and the compounding market (where these patients eventually land). It's visible only in longitudinal patient journey data.
FAQ
Can I buy Zepbound online without a prescription? No. Zepbound is a prescription medication. Any website claiming to sell Zepbound without a prescription is operating illegally and likely selling counterfeit or unsafe products. Legitimate telehealth platforms include a provider consultation and prescription as part of the service.
Is compounded tirzepatide the same as Zepbound? Compounded tirzepatide contains the same active ingredient (tirzepatide) as brand-name Zepbound, but it's not FDA-approved, not manufactured by Lilly, and not interchangeable with the brand product. It's prepared by a compounding pharmacy in response to an individual prescription. Efficacy and safety are expected to be similar, but compounded medications haven't undergone the same clinical trials and quality control as FDA-approved drugs.
How long does it take to get Zepbound delivered online? If you have a prescription and use a mail-order pharmacy, delivery takes 2 to 10 days depending on insurance verification. If you use a telehealth platform for compounded tirzepatide, delivery takes 2 to 7 days from intake completion. Lilly Direct typically takes 5 to 14 days due to insurance processing.
Do I need insurance to get Zepbound online? No, but without insurance, brand-name Zepbound costs $1,060 to $1,350 per month. Compounded tirzepatide through telehealth platforms costs $279 to $499 per month without insurance. Most patients without insurance choose the compounded option.
Can I use GoodRx for Zepbound ordered online? GoodRx coupons apply to retail pharmacy purchases, not mail-order in most cases. Some mail-order pharmacies accept GoodRx, but the discount is typically smaller than in-store. For brand Zepbound, the Lilly savings card (if you have commercial insurance) provides better savings than GoodRx.
What's the difference between Zepbound and Mounjaro? Both contain tirzepatide. Mounjaro is FDA-approved for type 2 diabetes. Zepbound is FDA-approved for weight loss. The medications are identical in formulation but marketed for different indications. Insurance coverage differs: many plans cover Mounjaro for diabetes but deny Zepbound for weight loss.
Is FormBlends compounded tirzepatide safe? FormBlends partners with 503A and 503B registered compounding pharmacies that follow USP standards for sterile compounding. Compounded medications are not FDA-approved, which means they haven't undergone the same review process as brand-name drugs. Safety and efficacy are expected to be similar to brand Zepbound, but individual results vary. All prescriptions are reviewed by licensed providers.
Can I switch from brand Zepbound to compounded tirzepatide? Yes, with your provider's guidance. The dosing is the same (both are measured in milligrams of tirzepatide), but the delivery method differs (pen vs vial and syringe). Your provider will confirm the equivalent dose and provide injection training if you're switching to the vial-based compounded version.
How do I know if an online Zepbound provider is legitimate? Verify three things: the prescribing provider is licensed in your state, the pharmacy is registered with your state board of pharmacy and FDA (503A or 503B), and the platform publishes transparent pricing and refund policies. Avoid platforms that require payment before provider review or that don't disclose the pharmacy's name and registration.
Does Medicare cover Zepbound ordered online? Medicare Part D covers Zepbound for type 2 diabetes (not weight loss) with prior authorization. Coverage for weight loss is excluded under current Medicare rules. If your Part D plan covers Zepbound, you can use mail-order pharmacy through your plan's preferred mail-order service. The Lilly savings card does not apply to Medicare patients.
Can I get a 90-day supply of Zepbound online? Some insurance plans and mail-order pharmacies allow 90-day fills, which reduces per-fill processing fees. The total cost is approximately 3x the monthly cost. For compounded tirzepatide through telehealth platforms, most platforms ship 4 to 8 weeks of supply per order, not 90 days, due to stability and dosing adjustment considerations.
What happens if my Zepbound shipment arrives warm? Zepbound must be refrigerated. If your shipment arrives above 46°F (check with a thermometer if you're unsure), contact the pharmacy immediately. Most mail-order pharmacies include temperature monitors in the packaging. If the medication was exposed to heat, the pharmacy will reship at no cost. Do not use medication that has been stored improperly.
Sources
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
- Curant Health. Aggregate Pharmacy Fulfillment Data for GLP-1 Medications. 2025.
- Digital Health Formulary Analysis. Telehealth Platform GLP-1 Offerings Survey. 2025.
- Lilly USA. Zepbound Prescribing Information. 2024.
- FDA. Compounding and the FDA: Questions and Answers. 2023.
- National Association of Boards of Pharmacy. Pharmacy Licensure and Registration Database. 2026.
- Centers for Medicare & Medicaid Services. Medicare Part D Coverage Determination and Appeals. 2025.
- GoodRx Research. Prior Authorization Denial Rates for GLP-1 Medications. 2024.
- American Telemedicine Association. State Telemedicine Policy Resource Center. 2026.
- Lilly USA. Lilly Direct Platform Overview. 2024.
- USP. General Chapter 797: Pharmaceutical Compounding - Sterile Preparations. 2023.
- Federal Poverty Guidelines. U.S. Department of Health and Human Services. 2026.
- State Medical Board Licensure Requirements. Federation of State Medical Boards. 2026.
- Novo Nordisk. Savings Card Program Terms and Conditions. 2025.
Footer disclaimers
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Zepbound, Mounjaro, and Rybelsus are registered trademarks of Eli Lilly and Company. Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. GoodRx, CVS, Walgreens, Costco, Express Scripts, and OptumRx are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →